[1] Similarly, a recent commentary in the journal Diabetes Care noted that microdosing semaglutide is off-label and not endorsed by the manufacturer, precisely because no clinical trials have validated its safety or efficacy
Innerbody.com
The goal is to create targeted therapies that can specifically neutralize harmful radicals without interfering with essential physiological processes
Structured programs often provide better adherence and measurable results
2018 Mar;24(3):243-248
Banerjee S, Bagchi B, Bhandary S, Kool A, Hoque NA, Biswas P, Pal K, Thakur P, Das K, Karmakar P, Das S (2018) Antimicrobial and biocompatible fluorescent hydroxyapatite-chitosan nanocomposite films for biomedical applications